In the U.S., women, especially in the age group of 19 to 50 years, are increasingly becoming health conscious owing to the growing incidence of chronic diseases, which is also one of the significant factors boosting the adoption of women’s health therapeutics in the country.
The increase in the population of women aged 65 and above is leading to a rise in the prevalence of medical conditions associated with aging such as osteoporosis and menopause. By 2050, the population of women aged 65 and above is expected to increase by 81%.
Moreover, increase in the number of women suffering from osteoporosis, obesity, depression, & menstrual disorders and high awareness in the target population are among the factors driving the market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account